The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1387
April 2, 2012
View Complete Issue         Table of Contents 2019 
Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain
April 2, 2012 (Issue: 1387)
The FDA has approved a new formulation (Exparel – Pacira) of the local anesthetic bupivacaine (Marcaine, and others) for use in the management of postsurgical pain in adults.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain
Article code: 1387b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.